QUILT-3.057: NANT Neoadjuvant Triple- Negative Breast Cancer (TNBC) Vaccine
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer (TNBC)
Interventions: DRUG: Leucovorin|DRUG: 5-Fluorouracil|DRUG: Aldoxorubicin HCl|DRUG: nab-Paclitaxel|BIOLOGICAL: ETBX-011|BIOLOGICAL: ETBX-051|BIOLOGICAL: ETBX-061|BIOLOGICAL: GI-4000|BIOLOGICAL: GI-6207|BIOLOGICAL: GI-6301|DRUG: Avelumab|BIOLOGICAL: ALT-803|BIOLOGICAL: haNK|DRUG: Cyclophosphamide|DRUG: Doxorubicin HCL|DRUG: paclitaxel
Sponsor: ImmunityBio, Inc.